C9024
Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- 2021 Status Change: Discontinue procedure or modifier code
- Effective Date: 2018-01-01
- Termination Date: 2018-12-31
- Medicare Coverage Status: Special coverage instructions apply
- BETOS Classification: Chemotherapy
Medicare has not assigned a fee schedule for this code
C9023
C9025 